BANK OF MONTREAL /CAN/ - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 60 filers reported holding IMMUNE DESIGN CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2018$1,0000.0%446
+93.1%
0.00%
Q3 2018$1,0000.0%231
-2.9%
0.00%
Q2 2018$1,000238
+852.0%
0.00%
Q1 2016$0
-100.0%
250.0%0.00%
Q4 2015$1,000250.0%0.00%
Q3 2015$0
-100.0%
250.0%0.00%
Q2 2015$1,0000.0%250.0%0.00%
Q1 2015$1,000250.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q1 2016
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,962,720$16,016,0006.52%
Abingworth LLP 197,300$1,610,0001.69%
NEXTHERA CAPITAL LP 85,138$695,0000.60%
Cormorant Asset Management, LP 432,990$3,533,0000.50%
SPHERA FUNDS MANAGEMENT LTD. 153,000$1,248,0000.32%
TFS CAPITAL LLC 102,685$838,0000.15%
RS INVESTMENT MANAGEMENT CO LLC 1,227,595$10,017,0000.10%
Eventide Asset Management 180,000$1,469,0000.09%
Focused Wealth Management, Inc 15,868$129,0000.06%
Spark Investment Management LLC 77,500$632,0000.06%
View complete list of IMMUNE DESIGN CORP shareholders